Drugs / Limbal stem cells (LSCs)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02148016 | Dec 2012 → Jun 2014 | hyperopia, myopia, pterygium | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Limbal stem cells (LSCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02148016 ↗ |
| Modality | Cell therapy | “Transplantation of stem cells represents an appealing therapeutic strategy in regenerative medicine” NCT02148016 ↗ |